ETR:EVT - Evotec Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€19.65 +0.15 (+0.77 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close€19.65
Today's Range€19.55 - €19.86
52-Week Range€7.91 - €22.50
Volume799,478 shs
Average Volume1.36 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates through two segments, EVT Execute and EVT Innovate. It offers drug discovery services, such as integrated services, target identification and validation, hit identification, compound management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, cell and protein production, and in vivo and in vitro pharmacology services, as well as absorption, distribution, metabolism, excretion, and toxicity services. The company is also involved in investing and developing proprietary assets, including early-stage discovery programs, as well as advanced drug candidates in the areas of diabetes and diabetic complications, inflammatory diseases, neuroscience, oncology, and pain and anti-infective. It has a drug discovery and development partnerships with Celgene Corporation; Novo Nordisk A/S; Sanofi; Almirall, S.A.; Ferring Pharmaceuticals; Centogene AG; Immuneering Corporation; and LEO Pharma A/S. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany.

Receive EVT News and Ratings via Email

Sign-up to receive the latest news and ratings for EVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+49-40-560810

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2,178
OptionableNot Optionable

Evotec (ETR:EVT) Frequently Asked Questions

What is Evotec's stock symbol?

Evotec trades on the ETR under the ticker symbol "EVT."

What price target have analysts set for EVT?

3 Wall Street analysts have issued twelve-month target prices for Evotec's stock. Their forecasts range from €20.00 to €26.00. On average, they anticipate Evotec's share price to reach €22.67 in the next year. This suggests a possible upside of 15.4% from the stock's current price. View Analyst Price Targets for Evotec.

What is the consensus analysts' recommendation for Evotec?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evotec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evotec.

Has Evotec been receiving favorable news coverage?

Media stories about EVT stock have trended somewhat positive this week, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Evotec earned a media sentiment score of 0.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the company's share price in the next few days.

Who are some of Evotec's key competitors?

Who are Evotec's key executives?

Evotec's management team includes the folowing people:
  • Dr. Werner Lanthaler, CEO & Member of Management Board (Age 51)
  • Mr. Enno Spillner, CFO & Member of Management Board (Age 49)
  • Dr. Cord Dohrmann, Chief Scientific Officer & Member of Management Board (Age 55)
  • Dr. Craig Johnstone, COO & Member of Management Board
  • Ms. Anja Bosler, Principal Accounting Officer and Sr. VP of Group Accounting

What is Evotec's stock price today?

One share of EVT stock can currently be purchased for approximately €19.65.

What is Evotec's official website?

The official website for Evotec is https://www.evotec.com/.

How can I contact Evotec?

Evotec's mailing address is Essener Bogen 7, HAMBURG, 22419, Germany. The company can be reached via phone at +49-40-560810.


MarketBeat Community Rating for Evotec (ETR EVT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  237
MarketBeat's community ratings are surveys of what our community members think about Evotec and other stocks. Vote "Outperform" if you believe EVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel